首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Pharmacodynamics of Doxycycline and Tetracycline against Staphylococcus pseudintermedius: Proposal of Canine-Specific Breakpoints for Doxycycline
【2h】

Pharmacodynamics of Doxycycline and Tetracycline against Staphylococcus pseudintermedius: Proposal of Canine-Specific Breakpoints for Doxycycline

机译:强力霉素和四环素对金黄色葡萄球菌的药效动力学:强力霉素犬特定断点的建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Doxycycline is a tetracycline that has been licensed for veterinary use in some countries, but no clinical breakpoints are available for veterinary pathogens. The objectives of this study were (i) to establish breakpoints for doxycycline and (ii) to evaluate the use of tetracycline as a surrogate to predict the doxycycline susceptibility of Staphylococcus pseudintermedius isolates. MICs and inhibition zone diameters were determined for 168 canine S. pseudintermedius isolates according to Clinical and Laboratory Standards Institute (CLSI) standards. Tetracycline resistance genes were detected by PCR, and time-kill curves were determined for representative strains. In vitro pharmacodynamic and target animal pharmacokinetic data were analyzed by Monte Carlo simulation (MCS) for the development of MIC interpretive criteria. Optimal zone diameter breakpoints were defined using the standard error rate-bounded method. The two drugs displayed bacteriostatic activity and bimodal MIC distributions. Doxycycline was more active than tetracycline in non-wild-type strains. MCS and target attainment analysis indicated a certainty of ≥90% for attaining an area under the curve (AUC)/MIC ratio of >25 with a standard dosage of doxycycline (5 mg/kg of body weight every 12 h) for strains with MICs of ≤0.125 μg/ml. Tetracycline predicted doxycycline susceptibility, but current tetracycline breakpoints were inappropriate for the interpretation of doxycycline susceptibility results. Accordingly, canine-specific doxycycline MIC breakpoints (susceptible, ≤0.125 μg/ml; intermediate, 0.25 μg/ml; resistant, ≥0.5 μg/ml) and zone diameter breakpoints (susceptible, ≥25 mm; intermediate, 21 to 24 mm; resistant, ≤20 mm) and surrogate tetracycline MIC breakpoints (susceptible, ≤0.25 μg/ml; intermediate, 0.5 μg/ml; resistant, ≥1 μg/ml) and zone diameter breakpoints (susceptible, ≥23 mm; intermediate, 18 to 22 mm; resistant, ≤17 mm) were proposed based on the data generated in this study.
机译:多西环素是一种四环素,在某些国家/地区已被许可用于兽医用途,但尚无针对兽性病原体的临床断点。这项研究的目的是(i)建立强力霉素的断点和(ii)评估四环素作为替代品预测金黄色葡萄球菌对多西环素敏感性的应用。根据临床和实验室标准协会(CLSI)标准,确定了168株假丝酵母链霉菌的MIC和抑制区直径。通过PCR检测四环素抗性基因,并确定代表性菌株的时间杀灭曲线。通过蒙特卡罗模拟(MCS)分析了体外药效学和目标动物的药代动力学数据,以建立MIC解释标准。使用标准误码率界定方法定义最佳区域直径断点。这两种药物显示出抑菌活性和双峰MIC分布。在非野生型菌株中,强力霉素比四环素更具活性。 MCS和目标达到率分析表明,对于带有MIC的菌株,使用标准剂量的强力霉素(每12小时5 mg / kg体重)时,曲线下面积(AUC)/ MIC比> 25时,确定性≥90% ≤0.125μg/ ml。四环素可预测强力霉素的药敏性,但当前的四环素断点不适用于强力霉素的药敏结果的解释。因此,犬特有的多西环素MIC断裂点(易感,≤0.125μg/ ml;中间,0.25μg/ ml;抗性,≥0.5μg/ ml)和区域直径断裂点(易感,≥25mm;中间,21至24 mm;耐受性≤20 mm)和替代四环素MIC断裂点(易感性≤0.25μg/ ml;中间0.5μg/ ml;抗性≥1μg/ ml)和区域直径断裂点(易感性≥23mm;中间18至根据这项研究产生的数据,提出了22毫米;电阻,≤17毫米)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号